CoChat

Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review

Open access
Correll, Christoph U., Cortese, Samuele, Croatto, Giovanni, Monaco, Francesco, Krinitski, Damir, Arrondo, Gonzalo, Ostinelli, Edoardo G., Zangani, Caroline, Fornaro, Michele, Estradé, Andrés, Fusar‐Poli, Paolo, Carvalho, Andre F., Solmi, Marco · 2021 · World Psychiatry
Cited by 153

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Top‐tier evidence on the safety/tolerability of 80 medications in children/adolescents with mental disorders has recently been reviewed in this jour­nal. To guide clinical practice, such data must be combined with evidence on efficacy and acceptability. Besides medications, psychosocial inter­ventions and brain stimulation techniques are treatment options for children/adolescents with mental disorders. For this umbrella review, we systematically searched network meta‐analyses (NMAs) and meta‐analyses (MAs) of randomized controlled trials (RCTs) evaluating 48 medications, 20 psychosocial interventions, and four brain stimulation techniques in children/adolescents with 52 different mental disorders or groups of mental disorders, reporting on 20 different efficacy/acceptability outcomes. Co‐primary outcomes were disease‐specific symptom reduction and all‐cause discontinuation (“acceptability”). We included 14 NMAs and 90 MAs, reporting on 15 mental disorders or groups of mental disorders. Overall, 21 medications outperformed placebo regarding the co‐primary outcomes, and three psychosocial interventions did so (while seven outperformed waiting list/no treatment). Based on the meta‐analytic evidence, the most convincing efficacy profile emerged for amphetamines, methylphenidate and, to a smaller extent, behavioral therapy in attention‐deficit/hyperactivity disorder; aripiprazole, risperidone and several psychosocial interventions in autism; risperidone and behavioral interventions in disruptive behavior disorders; several antipsychotics in schizophrenia spectrum disorders; fluoxetine, the combination of fluoxetine and cognitive behavioral therapy (CBT), and interpersonal therapy in depression; aripiprazole in mania; fluoxetine and group CBT in anxiety disorders; fluoxetine/selective serotonin reuptake inhibitors, CBT, and behavioral therapy with exposure and response prevention in obsessive‐compulsive disorder; CBT in post‐traumatic stress disorder; imipramine and alarm behavioral intervention in enuresis; behavioral therapy in encopresis; and family therapy in anorexia nervosa. Results from this umbrella review of interventions for mental disorders in children/adolescents provide evidence‐based information for clinical decision making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/wps.20881

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 81

  1. 10.1001/archpsyc.62.6.593 · DOI · Paper page
  2. 10.1001/jamapediatrics.2019.0337 · DOI · Paper page
  3. Pillay J, 2017, First‐ and second‐generation antipsychotics in children and young adults: systematic review update
  4. 10.1016/j.jaac.2016.12.013 · DOI
  5. 10.1001/jamapsychiatry.2017.0624 · DOI · Paper page
  6. 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  7. Otasowie J, 2014, Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents, Cochrane Database Syst Rev, 19, CD006997
  8. 10.1038/s41598-019-52205-6 · DOI
  9. 10.1016/j.brat.2015.10.008 · DOI
  10. 10.1007/s00787-018-1121-4 · DOI · Paper page
  11. 10.1177/1087054713504135 · DOI
  12. 10.1016/j.jaac.2016.03.007 · DOI · Paper page
  13. 10.3389/fpsyt.2019.00035 · DOI
  14. 10.1016/j.jad.2015.03.006 · DOI · Paper page
  15. 10.1177/108705470200600203 · DOI · Paper page
  16. Schachter HM, 2001, How efficacious and safe is short‐acting methylphenidate for the treatment of attention‐deficit disorder in children and adolescents? A meta‐analysis, CMAJ, 165, 1475
  17. 10.1089/cap.2014.0005 · DOI · Paper page
  18. 10.1016/j.jaac.2013.11.009 · DOI · Paper page
  19. 10.1089/cap.2018.0115 · DOI · Paper page
  20. 10.2147/NDT.S174622 · DOI
  21. 10.30773/pi.2019.0229 · DOI
  22. 10.1192/apt.22.3.146 · doi:10.1192/apt.22.3.146
  23. 10.1371/journal.pone.0172242 · DOI · Paper page
  24. 10.1186/s13034-015-0054-7 · DOI · Paper page
  25. 10.2147/NDT.S151802 · DOI
  26. 10.1016/j.jaac.2020.03.007 · DOI · Paper page
  27. 10.1111/1460-6984.12212 · DOI · Paper page
  28. Sturman N, 2017, Methylphenidate for children and adolescents with autism spectrum disorder, Cochrane Database Syst Rev, 11, CD011144
  29. Fletcher‐Watson S, 2014, Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD) (Review), Cochrane Database Syst Rev Interv, 3, CD008785
  30. 10.1016/j.rasd.2012.08.001 · DOI
  31. 10.1007/s10803-013-1952-2 · DOI
  32. 10.1186/s12888-020-02956-8 · DOI
  33. Reichow B, 2012, Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD), Cochrane Database Syst Rev, 7, CD008511
  34. 10.1371/journal.pone.0186502 · DOI · Paper page
  35. 10.1159/000356191 · DOI
  36. 10.1016/S0140-6736(04)16043-1 · DOI · Paper page
  37. 10.1111/j.1600-0447.2007.01018.x · DOI · Paper page
  38. Cox GR, 2014, Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents, Cochrane Database Syst Rev, 11, CD008324
  39. 10.3310/hta20430 · DOI · Paper page
  40. 10.1080/08039488.2020.1744037 · DOI
  41. 10.1002/da.22389 · DOI · Paper page
  42. 10.1176/appi.ajp.160.11.1919 · DOI · Paper page
  43. 10.1016/j.jaac.2019.08.480 · DOI · Paper page
  44. 10.1002/da.22978 · DOI · Paper page
  45. 10.1007/s00787-018-1189-x · DOI
  46. 10.1111/bju.14539 · doi:10.1111/bju.14539
  47. Caldwell PHY, 2020, Alarm interventions for nocturnal enuresis in children, Cochrane Database Syst Rev, 5, CD002911
  48. Caldwell PHY, 2016, Tricyclic and related drugs for nocturnal enuresis in children, Cochrane Database Syst Rev, 1, CD002117
  49. Caldwell PHY, 2013, Simple behavioural interventions for nocturnal enuresis in children, Cochrane Database Syst Rev, 7, CD003637
  50. Buckley BS, 2019, Conservative interventions for treating functional daytime urinary incontinence in children, Cochrane Database Syst Rev, 9, CD012367
  51. Deshpande AV, 2012, Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics), Cochrane Database Syst Rev, 12, CD002238
  52. 10.1038/s41598-018-34935-1 · doi:10.1038/s41598-018-34935-1
  53. Seida JC, 2012, First‐ and second‐ generation antipsychotics for children and young adults: comparative effectiveness
  54. Loy J, 2017, Atypical antipsychotic drugs for disruptive behaviour disorders in children and youths, Cochrane Database Syst Rev, 8, CD008559
  55. 10.1177/070674371506000203 · DOI · Paper page
  56. 10.1007/s00213-006-0537-6 · DOI
  57. 10.1186/s12888-015-0688-2 · DOI
  58. 10.3389/fpsyt.2018.00158 · DOI · Paper page
  59. 10.1002/eat.22042 · DOI · Paper page
  60. Fisher CA, 2019, Family therapy approaches for anorexia nervosa, Cochrane Database Syst Rev, 5, CD004780
  61. 10.1002/erv.2683 · DOI · Paper page
  62. 10.1037/ccp0000245 · DOI · Paper page
  63. 10.1016/j.euroneuro.2018.03.008 · DOI · Paper page
  64. 10.1007/s00787-019-01425-2 · DOI · Paper page
  65. 10.4103/0253-7613.117720 · DOI
  66. Kumar A, 2013, Atypical antipsychotics for psychosis in adolescents, Cochrane Database Syst Rev, 10, CD009582
  67. 10.2147/NDT.S121517 · DOI
  68. 10.1016/j.jad.2015.11.033 · DOI
  69. 10.1016/j.jaac.2011.05.011 · DOI
  70. Jochim J, 2019, Valproate for acute mania, Cochrane Database Syst Rev, 10, CD004052
  71. 10.1089/cap.2019.0161 · DOI
  72. 10.3310/hta20040 · DOI · Paper page
  73. 10.1002/hup.2498 · DOI
  74. 10.1093/jpepsy/jsu039 · DOI
  75. Brazzelli M, 2011, Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children, Cochrane Database Syst Rev, 12, CD0022400
  76. Miyahara M, 2017, Task‐oriented interventions for children with developmental co‐ordination disorder, Cochrane Database Syst Rev, 7, CD010914
  77. 10.1002/ebch.1916 · DOI · Paper page
  78. 10.1542/peds.2010-1361 · DOI · Paper page
  79. 10.1542/peds.2010-1360 · DOI · Paper page
  80. 10.1542/peds.2015-0743 · DOI · Paper page
  81. 10.3109/08039488.2014.941395 · DOI

Cited by

See all 153

Metadata

Authors
Correll, C. U., Cortese, S., Croatto, G., Monaco, F., Krinitski, D., Arrondo, G., Ostinelli, E. G., Zangani, C., Fornaro, M., Estradé, A., Fusar‐Poli, P., Carvalho, A. F., & Solmi, M.
Venue
World Psychiatry
Publisher
Wiley
Published
2021-05-18
Volume
20
Issue
2
Pages
244-275
ISSN
  • 1723-8617 (ISSN-L)
  • 2051-5545
OpenAlex
W3162418457
Cited by
153
References
47
FWCI
17.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.